Total Funding
44
49
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81079
Entegrion is a life sciences company dedicated to providing innovative solutions.
Past Role: Sphinx Pharmaceuticals, CEO
John B. Mowell: ChairmanPast Role: Entegrion, Chairman and President
About the Company
Entegrion is a life sciences company dedicated to providing innovative solutions. Their products bring about major changes to the critical pathways in the diagnosis and treatment of patient coagulopathies, enabling clinicians to rapidly and effectively advance care in both the hospital and field environments.
They partner with leading scientists,
clinicians, and industry specialists to provide products that enable doctors to improve clinical outcomes for patients whose hemostatic state may be compromised.
